Wei et al. have reported that CD133− glioma cells are not capable of producing glioma in immunocompromised animal models in contrast to CD133+ glioma cells; it has been found that the PI3K activity and the phosphorylations of Akt on S473 and T308 are considerably increased in CD133+ population [44]. This evidence concerns the gene PROM1 and glioma.